Abstract:BACKGROUND:Circulating tumor cells (CTCs) have shown prognostic relevance in many cancer types. However, the majority of current CTC capture methods rely on positive selection techniques that require a priori knowledge about the surface protein expression of disseminated CTCs, which are known to be a dynamic population. METHODS:We developed a microfluidic CTC capture chip that incorporated a nanoroughened glass substrate for capturing CTCs from blood samples. Our CTC capture chip utilized the differential adhesion preference of cancer cells to nanoroughened etched glass surfaces as compared to normal blood cells and thus did not depend on the physical size or surface protein expression of CTCs. RESULTS:The microfluidic CTC capture chip was able to achieve a superior capture yield for both epithelial cell adhesion molecule positive (EpCAM+) and EpCAM- cancer cells in blood samples. Additionally, the microfluidic CTC chip captured CTCs undergoing transforming growth factor beta-induced epithelial-to-mesenchymal transition (TGF-β-induced EMT) with dynamically down-regulated EpCAM expression. In a mouse model of human breast cancer using EpCAM positive and negative cell lines, the number of CTCs captured correlated positively with the size of the primary tumor and was independent of their EpCAM expression. Furthermore, in a syngeneic mouse model of lung cancer using cell lines with differential metastasis capability, CTCs were captured from all mice with detectable primary tumors independent of the cell lines' metastatic ability. CONCLUSIONS:The microfluidic CTC capture chip using a novel nanoroughened glass substrate is broadly applicable to capturing heterogeneous CTC populations of clinical interest independent of their surface marker expression and metastatic propensity. We were able to capture CTCs from a non-metastatic lung cancer model, demonstrating the potential of the chip to collect the entirety of CTC populations including subgroups of distinct biological and phenotypical properties. Further exploration of the biological potential of metastatic and presumably non-metastatic CTCs captured using the microfluidic chip will yield insights into their relevant differences and their effects on tumor progression and cancer outcomes.

Isolation and Elution of Hep3B Circulating Tumor Cells Using a Dual-Functional Herringbone Chip

Highly Efficient Capture and Harvest of Circulating Tumor Cells on A Microfluidic Chip Integrated with Herringbone and Micropost Arrays

Isolation and Retrieval of Circulating Tumor Cells on A Microchip with Double Parallel Layers of Herringbone Structure

Microfluidic Chip for Isolation of Viable Circulating Tumor Cells of Hepatocellular Carcinoma for Their Culture and Drug Sensitivity Assay

Self-Sterilizing and Regeneratable Microchip for the Precise Capture and Recovery of Viable Circulating Tumor Cells from Patients with Cancer.

On-chip Circulating Tumor Cells Isolation Based on Membrane Filtration and Immuno-Magnetic Bead Clump Capture

Isolation of circulating tumor cells using a microvortex-generating herringbone-chip

Combination of Antibody-Coated, Physical-Based Microfluidic Chip with Wave-Shaped Arrays for Isolating Circulating Tumor Cells

Isolation of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Using a Novel Cell Separation Strategy

Three-Dimensional microfluidic chip with twin-layer herringbone structure for high efficient tumor cell capture and release via Antibody-conjugated magnetic microbeads.

Enhanced Isolation and Release of Circulating Tumor Cells Using Nanoparticle Binding and Ligand Exchange in a Microfluidic Chip.

Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells.

Accurate Isolation of Circulating Tumor Cells via a Heterovalent DNA Framework Recognition Element-Functionalized Microfluidic Chip

Microfluidic chip combined with magnetic-activated cell sorting technology for tumor antigen-independent sorting of circulating hepatocellular carcinoma cells

High-performance Assay of HepG2 Cells Through Inertial Separation in a Microfluidic Chip Coupled with Fluorescence and Photoelectrochemical Detection

Aptamer-Mediated Transparent-Biocompatible Nanostructured Surfaces for Hepotocellular Circulating Tumor Cells Enrichment

Efficient Isolation and Phenotypic Profiling of Circulating Hepatocellular Carcinoma Cells Via a Combinatorial-Antibody-Functionalized Microfluidic Synergetic-Chip.

High-Efficiency Isolation and Rapid Identification of Heterogeneous Circulating Tumor Cells (ctcs) Using Dual-Antibody-Modified Fluorescent-Magnetic Nanoparticles

High-purity Capture of CTCs Based on Micro-Beads Enhanced Isolation by Size of Epithelial Tumor Cells (ISET) Method.

Nanoroughened Adhesion-Based Capture of Circulating Tumor Cells with Heterogeneous Expression and Metastatic Characteristics.

Reversible capture and release of circulating tumor cells on a three-dimensional conductive interface to improve cell purity for gene mutation analysis